Back to search
Drug Resistant Partial Onset Seizure
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Drug Resistant Partial Onset Seizure trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Drug Resistant Partial Onset Seizure trials you may qualify forThe purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy
The purpose of this study is to assess the long-term safety and tolerability of CVL-865 as adjunctive therapy in participants with focal onset seizures.
The goal of this clinical trial is to learn if CVL-865, when taken regularly with other anti-seizure medicines, works to prevent seizures in adults with drug-re…